Study of Pregnancy Pathologies Associated With Placental Abnormalities

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-52
SponsorUniversity Hospital, Grenoble

About this trial

Pregnancy pathologies can occur from implantation until childbirth. The investigators are interested in the development mechanisms of these pathologies and aim to develop therapies to treat them.

The investigators need to collect samples, especially placental samples, following abortions and term and premature deliveries. Abortions will allow investigators to have non-pathological placental material up to 13 weeks. This material will serve as a reference for the understanding of the histological changes that occur in normal placentas collected at term of pregnancy. The latter will, in turn, be compared with the placentas collected during premature deliveries. Also, the abortion product will be cultivated in an environment mimicking the pathology of pre-eclampsia. This study will allow investigators to advance their understanding of the pathophysiological mechanisms of the placenta. The investigators are internationally recognized for their research on these pathologies.

Eligibility criteria

Qualifiers

Admitted to the CHUGA for a birth or an abortion.

Pregnant women consenting to the collection of their fetal placenta membranes, during premature deliveries or at term of pregnancy OR Women performing an abortion consenting to the collection of their abortion products.

Having signed a consent

Affiliated with social security

Disqualifiers

Placental sample or abortion product unavailable (not collected or necessary for treatment).

Patient with known positive HIV or Hepatitis B or Hepatitis C serology or at risk according to the infectious safety criteria applied by the EFS.

hemoglobin <7d / dL or hemoglobin <10g / dL if she suffers from a cardio-respiratory pathology).

Patient protected by law (minor, hospitalized under duress, subject to a legal protection measure by guardianship or curatorship, deprived of liberty by judicial or administrative decision)

Trial design

Treatments tested in this trial

  • Histology

Treatment groups

800 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

University Hospital, Grenoble

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Collaborator